nitroglycerin has been researched along with Hepatocellular Carcinoma in 4 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether the addition of nitroglycerine to transcatheter arterial (chemo)embolization (TAE/TACE) can increase the delivery and effectiveness of TAE/TACE in patients with hepatocellular carcinoma (HCC) by dual-energy CT." | 9.16 | Nitroglycerine use in transcatheter arterial (chemo)embolization in patients with hepatocellular carcinoma and dual-energy CT assessment of Lipiodol retention. ( Chuang, MT; Lin, XZ; Liu, YS; Tsai, HM; Tsai, YS, 2012) |
| "To determine the hemodynamic effects of intra-arterial nitroglycerin on hepatocellular carcinoma (HCC) using 2-dimensional (2D) perfusion angiography." | 8.02 | Quantitative Assessment of the Hemodynamic Effects of Intra-Arterial Nitroglycerin on Hepatocellular Carcinoma using Two-Dimensional Perfusion Angiography. ( Brunson, C; Hennemeyer, C; Khan, A; McGregor, H; Patel, M; Woodhead, G, 2021) |
| "Addition of nitroglycerine (NTG) to transcatheter arterial embolization/transarterial chemoembolization (TAE/TACE) has been shown to increase deposition of Lipiodol emulsion in hepatocellular carcinoma (HCC) tumors." | 7.88 | Nitroglycerine use in transcatheter arterial (chemo) embolization in patients with hepatocellular carcinoma: Five-year retrospective study. ( Chuang, MT; Lin, CY; Liu, YS; Ou, MC; Tsai, YS; Wang, CK, 2018) |
| "To investigate whether the addition of nitroglycerine to transcatheter arterial (chemo)embolization (TAE/TACE) can increase the delivery and effectiveness of TAE/TACE in patients with hepatocellular carcinoma (HCC) by dual-energy CT." | 5.16 | Nitroglycerine use in transcatheter arterial (chemo)embolization in patients with hepatocellular carcinoma and dual-energy CT assessment of Lipiodol retention. ( Chuang, MT; Lin, XZ; Liu, YS; Tsai, HM; Tsai, YS, 2012) |
| "To determine the hemodynamic effects of intra-arterial nitroglycerin on hepatocellular carcinoma (HCC) using 2-dimensional (2D) perfusion angiography." | 4.02 | Quantitative Assessment of the Hemodynamic Effects of Intra-Arterial Nitroglycerin on Hepatocellular Carcinoma using Two-Dimensional Perfusion Angiography. ( Brunson, C; Hennemeyer, C; Khan, A; McGregor, H; Patel, M; Woodhead, G, 2021) |
| "Addition of nitroglycerine (NTG) to transcatheter arterial embolization/transarterial chemoembolization (TAE/TACE) has been shown to increase deposition of Lipiodol emulsion in hepatocellular carcinoma (HCC) tumors." | 3.88 | Nitroglycerine use in transcatheter arterial (chemo) embolization in patients with hepatocellular carcinoma: Five-year retrospective study. ( Chuang, MT; Lin, CY; Liu, YS; Ou, MC; Tsai, YS; Wang, CK, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| McGregor, H | 1 |
| Brunson, C | 1 |
| Woodhead, G | 1 |
| Khan, A | 1 |
| Hennemeyer, C | 1 |
| Patel, M | 1 |
| Liu, YS | 2 |
| Lin, CY | 1 |
| Chuang, MT | 2 |
| Tsai, YS | 2 |
| Wang, CK | 1 |
| Ou, MC | 1 |
| Tsai, HM | 1 |
| Lin, XZ | 1 |
| Bosch, J | 1 |
| Bruix, J | 1 |
| Mas, A | 1 |
| Navasa, M | 1 |
| Rodés, J | 1 |
1 review available for nitroglycerin and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Rolling review: the treatment of major complications of cirrhosis.
Topics: Adrenergic beta-Antagonists; Ascites; Carcinoma, Hepatocellular; Catheterization; Diuretics; Hemorrh | 1994 |
1 trial available for nitroglycerin and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Nitroglycerine use in transcatheter arterial (chemo)embolization in patients with hepatocellular carcinoma and dual-energy CT assessment of Lipiodol retention.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolizati | 2012 |
2 other studies available for nitroglycerin and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Quantitative Assessment of the Hemodynamic Effects of Intra-Arterial Nitroglycerin on Hepatocellular Carcinoma using Two-Dimensional Perfusion Angiography.
Topics: Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; | 2021 |
Nitroglycerine use in transcatheter arterial (chemo) embolization in patients with hepatocellular carcinoma: Five-year retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined | 2018 |